Source comparison
Best AOD-9604 Dosage for Lipolysis: Protocol Comparison
Standard Single-Dose 400–500 mcg Once daily Morning fasted (upon waking) 12–16 weeks 2.8–3.4 kg mean reduction Most common protocol. Balances efficacy with compliance; suitable for most research applications Split-Dose 250 mcg × 2 Twice daily Morning fasted +
This comparison does not assign a generated winner or score.
- Standard Single-Dose
- 400–500 mcg
- Once daily
- Morning fasted (upon waking)
- 12–16 weeks
- 2.8–3.4 kg mean reduction
- Most common protocol. Balances efficacy with compliance; suitable for most research applications
- Split-Dose
- 250 mcg × 2
- Twice daily
- Morning fasted + pre-dinner
- 3.2–4.1 kg mean reduction
- 15–20% superior fat loss versus single-dose; requires higher adherence; best for obesity research models
- Low-Dose Maintenance
- 200–300 mcg
- Morning fasted
- 8–12 weeks
- 1.8–2.4 kg mean reduction
- Appropriate for lean subjects (sub-15% body fat); lower side effect incidence; extended cycle tolerance
- High-Dose Obesity Protocol
- 500–750 mcg
- Once daily or split
- Morning fasted ± evening
- 16–24 weeks
- 4.0–5.2 kg mean reduction
- Used in severe obesity trials (BMI >35); marginal benefit above 500 mcg; increased injection site reactions
- Pre-Activity Timing
- 300–400 mcg
- 30–45 min pre-cardio (fasted)
- 3.0–3.8 kg mean reduction
- Combines peptide mobilisation with exercise oxidation; logistically complex; research on trained subjects